Skip to main content

Nixon Peabody LLP

  • People
  • Capabilities
  • Insights
  • About
Trending Topics
    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    Practices

    View All

    • Affordable Housing
    • Community Development Finance
    • Corporate & Finance
    • Cybersecurity & Privacy
    • Entertainment & Media
    • Environmental
    • Franchising & Distribution
    • Government Investigations & White Collar Defense
    • Healthcare
    • Intellectual Property
    • International Services
    • Labor, Employment, and Benefits
    • Litigation
    • Private Wealth & Advisory
    • Project Finance
    • Public Finance
    • Real Estate
    • Regulatory & Government Relations
    Industries

    View All

    • Aviation
    • Cannabis
    • Consumer
    • Energy
    • Financial Services
    • Healthcare
    • Higher Education
    • Infrastructure
    • Manufacturing
    • Nonprofit Organizations
    • Real Estate
    • Sports & Stadiums
    • Technology
    Value-Added Services

    View All

    • Alternative Fee Arrangements

      Developing innovative pricing structures and alternative fee agreement models that deliver additional value for our clients.

    • Continuing Education

      Advancing professional knowledge and offering credits for attorneys, staff and other professionals.

    • Crisis Advisory

      Helping clients respond correctly when a crisis occurs.

    • DEI Strategic Services

      Providing our clients with legal, strategic, and practical advice to make transformational changes in their organizations.

    • eDiscovery

      Leveraging law and technology to deliver sound solutions.

    • Environmental, Social, and Governance (ESG)

      We help clients create positive return on investments in people, products, and the planet.

    • Global Services

      Delivering seamless service through partnerships across the globe.

    • Innovation

      Leveraging leading-edge technology to guide change and create seamless, collaborative experiences for clients and attorneys.

    • IPED

      Industry-leading conferences focused on affordable housing, tax credits, and more.

    • Legal Project Management

      Providing actionable information to support strategic decision-making.

    • Legally Green

      Teaming with clients to advance sustainable projects, mitigate the effects of climate change, and protect our planet.

    • Nixon Peabody Trust Company

      Offering a range of investment management and fiduciary services.

    • NP Capital Connector

      Bringing together companies and investors for tomorrow’s new deals.

    • NP Second Opinion

      Offering fresh insights on cases that are delayed, over budget, or off-target from the desired resolution.

    • NP Trial

      Courtroom-ready lawyers who can resolve disputes early on clients’ terms or prevail at trial before a judge or jury.

    • Social Impact

      Creating positive impact in our communities through increasing equity, access, and opportunity.

    • Women in Dealmaking

      We provide strategic counsel on complex corporate transactions and unite dynamic women in the dealmaking arena.

    1. Home
    2. Insights
    3. Alerts
    4. Substantial regulatory changes proposed for New York’s clinical laboratories and blood banks

      Alerts

    Alert / Healthcare

    Substantial regulatory changes proposed for New York’s clinical laboratories and blood banks

    March 28, 2022

    LinkedInX (Twitter)EmailCopy URL

    By Justin Pfeiffer

    New York’s Department of Health published proposed regulations changing the requirements governing clinical laboratories and blood banks—the public comment period is open.

    What’s the impact?

    • The proposed regulations include new and/or revised duties, requirements, and qualifications for laboratory directors, assistant laboratory directors, and several other positions
    • Character and competence review proposed for laboratory directors and owners of clinical laboratories and blood banks
    • If adopted, the new regs would establish a “single use” permit type to authorize testing for a limited period of time and/or for a limited number of tests

    DOWNLOAD

    Proposed NY lab regulations (PDF)

    After a long development cycle, the New York State Department of Health (NYSDOH) has published proposed regulations that would make significant changes to the requirements governing clinical laboratories and blood banks. If adopted in their current form, the new regulations would:

    • Authorize NYSDOH to review, when processing clinical laboratory and blood bank permit applications, the character and competence of the laboratory director and all owners of the laboratory or blood bank. The regulations specify numerous review factors, along with any “other factor having a direct bearing on the laboratory director and/or owner’s ability to provide high quality laboratory services.”
    • Clarify and amend the processes related to the application, denial, and termination of provisional permits for categories of testing.
    • Establish a new “single use” permit that may be issued on a patient-specific or test-specific basis. Such permits may be issued for a limited period of time and/or for a limited number of tests, based on several criteria. Significantly, NYSDOH would be able to issue single use permits to laboratories that do not otherwise hold a clinical laboratory or blood bank permit.
    • Impose new responsibilities on any assistant laboratory director who possesses the sole certificate of qualification for a category of tests.
    • Expand the number of clinical laboratories or blood banks at which a person may serve as laboratory director or assistant director, from two (2) to five (5).
    • Require laboratory directors and assistant directors to be present on-site, at each laboratory where such person serves, at least eight (8) hours per week, and to be immediately available remotely at all other times. NYSDOH will consider requests to be present on-site for less than eight (8) hours at a particular location, and may require directors and assistant directors to be present for more than eight (8) hours, depending on several factors.
    • State that the laboratory director and all owners of a clinical laboratory or blood bank are “jointly and severally responsible” for the facility’s operations, and responsible for a “quality management system for the delivery of services.”
    • Provide that failure to notify NYSDOH of the resignation, termination, death, or physical or mental incapacitation of the laboratory director within 60 calendar days shall result in the voiding of the permit. Failure to provide such notifications with respect to a sole assistant director would void any specific testing category for which such assistant director is responsible.
    • Establish new or substantially revised duties and qualifications of laboratory supervisors, clinical laboratory technologists, clinical laboratory technicians, cytotechnologists, and histological technicians.
    • Establish new communicable disease reporting requirements.

    The new character and competence requirements would be a significant change to NYSDOH’s permitting process. However, NYSDOH said little about them in the regulatory paperwork, focusing more on the regulatory flexibilities that the regulations would provide.

    Among other goals, NYSDOH stated that these regulations would enable the agency to more quickly issue limited permits in a public health emergency—in particular, by providing a process for issuing provisional permits in the category of virology, as well as “single use” permits to laboratories not currently licensed by NYSDOH.

    The new regulations also appear aimed at addressing the current shortage of laboratory director candidates—in particular, by allowing assistant directors to be treated as laboratory directors for certain categories of testing (“sole assistant directors”), and by increasing the number of directorships that may be held from two to five. At the same time, the regulations specify new on-site presence requirements for laboratory directors and sole assistant directors. Similarly, the regulations would expand the pool of laboratory supervisor candidates, by expanding the eligibility criteria.

    The comment period for the regulations expires on May 23, 2022. 

    Locations

    New York CityLong IslandRochesterAlbany

    Practices

    HealthcareHealthcare Dispute ResolutionHealthcare Regulatory & ComplianceLife SciencesManaged Care Contracts & Network DevelopmentMedicare, Medicaid, and Other Government Payors

    Industries

    Healthcare

    Insights And Happenings

    • Alert

      Centers for Medicare & Medicaid Services issues first civil monetary penalty notices to hospitals

      June 23, 2022
    • Alert

      OCR issues guidance on HIPAA-compliant use of audio-only telehealth

      June 21, 2022
    • Press Release

      Nixon Peabody expands Healthcare practice with another returning attorney

      June 7, 2022
    The foregoing has been prepared for the general information of clients and friends of the firm. It is not meant to provide legal advice with respect to any specific matter and should not be acted upon without professional counsel. If you have any questions or require any further information regarding these or other related matters, please contact your regular Nixon Peabody LLP representative. This material may be considered advertising under certain rules of professional conduct.

    Subscribe to stay informed of the latest legal news, alerts, and business trends.Subscribe

    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    • Cookie Preferences
    • Privacy Policy
    • Terms of Use
    • Accessibility Statement
    • Statement of Client Rights
    • Purchase Order Terms & Conditions
    • Nixon Peabody International LLC
    • PAL
    © 2025 Nixon Peabody. All rights reserved